Abbott Laboratories

ABTNYSE · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

1.73B

on 2026-06-30, from 1.74B on 2024-03-31 10-Q ↗

Newest

No limit

S-3ASR of 2026-02-23. An automatic shelf: the form sets no dollar limit. 2 prospectus supplements filed under it since. S-3ASR ↗

None

No at-the-market programme on file in the last 30 months.

Warrants

The 10-Q filed 2026-07-28 is not read yet.

Cash

Four quarters of operating cash flow to 2026-06-30 are not all on file.

Raised: 1 of its filings are not read yet.

Also on file: $1.00B notes, 2026-02-23 424B5 ↗ · $20.00B senior notes, 2026-02-23 8-K ↗ · $20.00B senior notes, 2026-03-09 8-K ↗